Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 111 for “"Angiopathy"”.
-
Characterizing Plasma Biomarkers of Cerebral Amyloid Angiopathy
BACKGROUND: Cerebral Amyloid Angiopathy (CAA) is characterized by the progressive deposition of beta-amyloid in cortical and leptomeningeal small vessels leading to hemorrhagic stroke and dementia. While CAA is diagnosed using Boston Criteria 2.0, they are not always possible to apply. Plasma …
-
Identifying the Neuropsychological Profile of Cerebral Amyloid Angiopathy
Cerebral amyloid angiopathy (CAA) occurs when the protein, beta-amyloid, deposits onto blood vessels in the brain, often resulting in cognitive impairment. This study aims to identify the neuropsychological profile of CAA by comparing CAA participants to the normal population and …
-
The Neuroinflammatory Response Associated to Cerebral Amyloid Angiopathy (CAA)
Cerebral amyloid angiopathy (CAA) is characterized by the cerebrovascular deposition of amyloid. The mechanisms underlying the contribution of CAA to neurodegeneration are not fully understood. In this dissertation, there are three main chapters. The first chapter investigates existing evidence …
-
Cerebral Amyloid Angiopathy and Transition Metals in Alzheimer's Disease
… disease-related iron overload. Cerebral amyloid angiopathy (CAA) is a vascular manifestation of Alzheimer's disease present to some degree in up to 95% of Alzheimer's disease patients. This vasculopathy results in vascular inflammation and fragility which produces clinically detectable bleeding …
-
Neuroimaging Correlates of Gait Control in Cerebral Amyloid Angiopathy
Cerebral amyloid angiopathy (CAA) is the second most common subtype of cerebral small vessel disease (CSVD) and is characterized by the buildup of beta-amyloid protein in the walls of small-medium sized arteries and arterioles of the leptomeninges. Much is known about common clinical manifestations …
-
On the Pathophysiology and Prevalence of Cerebral Amyloid Angiopathy
Radboud University, 06 december 2021
-
Microglia and Complement in Alzheimer's Disease with Cerebral Amyloid Angiopathy
… and phenotypic heterogeneity. Cerebral amyloid angiopathy (CAA) is a common, yet frequently overlooked, pathology associated with AD. A pathological hallmark of AD consists of extracellular amyloid-beta (Aβ) deposits, while CAA</p> <p>manifests with deposition Aβ within the smooth muscle layer …
-
Cerebral amyloid angiopathy: novel insights on prevalence and fluid biomarkers
Contains fulltext : 304142.pdf (Publisher’s version ) (Open Access)
-
Proteomic secrets of the cerebrospinal fluid: Understanding cerebral amyloid angiopathy
Contains fulltext : 311849.pdf (Publisher’s version ) (Open Access)
-
Associations between serum lipids and cerebral amyloid angiopathy in longitudinal studies of aging
BACKGROUND: Cerebral amyloid angiopathy (CAA) is a common age-related vascular disorder associated with cognitive decline and dementia. The relationship between CAA and serum lipid levels in aging is minimally investigated. Thus, we investigated the association of CAA with serum lipid levels in two …
-
Cerebral Amyloid Angiopathy-Causing Beta-Amyloid Variants Have Altered Effects on the Clotting System
Cerebral amyloid angiopathy (CAA), where beta-amyloid (Aβ) deposits around cerebral blood vessels, is a major contributor of vascular dysfunction in Alzheimer's disease (AD) patients. However, the molecular mechanism underlying CAA formation and CAA-induced cerebrovascular pathologies, including …
-
Apolipoprotein E Immunotherapy for the Preclinical Treatment of Alzheimer Disease and Cerebral Amyloid Angiopathy
… in cerebral blood vessels as cerebral amyloid angiopathy (CAA). The presence of pathogenic APOE may act as a “seed” to promote Aβ fibrillization, and our lab has previously shown that reducing APOE protein levels with several genetic approaches in mice results in drastically less Aβ pathology. …
-
Observations on cerebral amyloid angiopathy and microvascular pathology in Alzheimer's disease and vascular dementia
… in the cerebrovasculature (cerebral amyloid angiopathy), is surprisingly common in vascular dementia, and frequently more severe than in Alzheimer's disease. In Alzheimer's disease, cerebral amyloid angiopathy is associated with ischemic white matter disease, but in vascular dementia, …
-
Molecular Mechanisms in Amyloid Disorders. Novel Treatment Options in Hereditary Cystatin C Amyloid Angiopathy.
… treatment. In hereditary cystatin C amyloid angiopathy (HCCAA), a cystatin C variant is deposited in arterial walls and causes brain hemorrhage in young adults. Although carriers of the cystatin C variant may be easily identified by genetic testing, no treatments are available. In the present …
-
The Role of Perivascular Fibrosis In Post-Stroke Glymphatic Impairment and Cerebral Amyloid Angiopathy
… build-up of Aβ, termed cerebral amyloid angiopathy (CAA). I hypothesize that an abnormal pattern of extracellular matrix deposition within the vascular basement membrane, termed fibrosis, impairs Aβ drainage from the aged brain after stroke. I further hypothesize that inhibition of …
-
Microenvironmental Heterogeneity and Tau as a Therapeutic Alternative in Alzheimer’s Disease with Cerebral Amyloid Angiopathy
Alzheimer’s disease (AD) and cerebral amyloid angiopathy (CAA) are closely linked neurodegenerative conditions characterized by amyloid-β (Aβ) deposition in the brain parenchyma and vasculature, respectively. Although these pathologies frequently cooccur, they are often studied as independent …
Page 1 of 6